- United States
- /
- Personal Products
- /
- NasdaqCM:NATR
Nature's Sunshine Products Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nature's Sunshine Products (NASDAQ:NATR) Full Year 2024 Results
Key Financial Results
- Revenue: US$454.4m (up 2.0% from FY 2023).
- Net income: US$7.70m (down 49% from FY 2023).
- Profit margin: 1.7% (down from 3.4% in FY 2023). The decrease in margin was driven by higher expenses.
- EPS: US$0.41 (down from US$0.79 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nature's Sunshine Products Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 38%.
The primary driver behind last 12 months revenue was the Asia segment contributing a total revenue of US$207.8m (46% of total revenue). The largest operating expense was General & Administrative costs, amounting to US$164.0m (52% of total expenses). Explore how NATR's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 2.2% p.a. on average during the next 2 years, compared to a 3.5% growth forecast for the Personal Products industry in the US.
Performance of the American Personal Products industry.
The company's shares are down 5.0% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Nature's Sunshine Products you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Nature's Sunshine Products might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:NATR
Nature's Sunshine Products
A natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally.
Flawless balance sheet and slightly overvalued.
Similar Companies
Market Insights
Community Narratives


Recently Updated Narratives
TAV Havalimanlari Holding will fly high with 25.68% revenue growth

Fiducian: Compliance Clouds or Value Opportunity?

Q3 Outlook modestly optimistic
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.
